Beginning Jan. 1, 2018, certain drugs will have new limitations or will require utilization management — e.g., prior authorization (PA) requirements, step therapy (ST) modifications and nonformulary (NF) changes — under the Humana commercial and Medicare formularies for the 2018 plan year. These changes could mean higher costs or new requirements for Humana-covered patients who use these drugs. Humana encourages the use of generic and cost-effective brand medications whenever possible.
Also, effective Jan. 1, 2018, Humana will limit the amount of prescription opioid pain medications that can be filled at one time. Pharmacies will be allowed only to fill an opioid pain medication prescription that is for 30 days or less.